Software developer iCAD launched CAD software at the European Congress of Radiology that is designed for use with full-field digital mammography systems. The product, called CompanionCAD, evolved as part of a joint R&D program involving iCAD and Fischer
Software developer iCAD launched CAD software at the European Congress of Radiology that is designed for use with full-field digital mammography systems. The product, called CompanionCAD, evolved as part of a joint R&D program involving iCAD and Fischer Imaging. Fischer Imaging is now marketing iCAD's CompanionCAD software for sale in Europe as an option with its SenoScan TrueView Digital Mammography System. CompanionCAD is based on iCAD's latest software for the early detection of breast cancer. The first European installations are expected by midsummer. Marketing of CompanionCAD in the U.S. awaits FDA approval of the product.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.